Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Calibra's insulin patch-pen receives FDA clearance

This article was originally published in Clinica

Executive Summary

The US FDA has granted 510(k) clearance for Calibra Medical's Finesse insulin patch-pen. It is a novel way to deliver the hormone and simplifies mealtime insulin dosing, the Redwood City, California firm claims. The patch measures 5cm long, 2.5cm wide and is 0.6cm thick, and adheres to patients' skin. It can deliver prescribed amounts of insulin over several days, and stays in place when the patient showers or exercises. Conventional syringes and pens are more difficult to use and there is a social stigma attached to injecting insulin at mealtimes, Calibra says. The firm has started a clinical trial of the device in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT045337

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel